Overview

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The primary protocol objective is to assess the impact of substituting pulsed reduced dose radiotherapy (pRDR) for standard radiation therapy in the upfront treatment of glioblastoma (GBM) on disease progression.
Phase:
Phase 2
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Temozolomide